<DOC>
	<DOCNO>NCT01040286</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Flurbiprofen Chip versus Chlorhexidine chip ( Periochip® ) therapy adult chronic periodontitis .</brief_summary>
	<brief_title>The Efficacy Safety Flurbiprofen Chip Versus Chlorhexidine Chip ( Periochip® ) Therapy Adult Chronic Periodontitis</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Flurbiprofen</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>1 . Signed date informed consent form 2 . Good general health 3 . Male female subject age &gt; 21 year old 4 . Availability 9 week duration study 5 . Chronic periodontal disease natural teeth characterize presence least 2 teeth periodontal pocket 59 mm depth ( potential target teeth ) demonstrate bleed probe without involve apex tooth confirm dental Xray . 6 . Females childbearing potential must nonpregnant nonlactating entry agree use adequate method ( Oral parenteral hormonal contraceptive ; Intrauterine device ; barrier spermicide ) birth control study . 1 . An exist aggressive periodontitis . 2 . Presence oral local mechanical factor could ( opinion investigator ) influence outcome study . 3 . Presence orthodontic appliance , removable appliance , impinge tissue assess . 4 . Soft hard tissue tumours oral cavity . 5 . Presence dental implant adjacent target tooth . 6 . Presence 2 adjacent periodontal pocket potential target tooth . 7 . Periodontal pocket 9 mm depth , and/or class 2 3 furcation involvement , potential target tooth . 8 . Systemic antibiotic therapy periodontal/mechanical/local delivery therapy within 6 week prior study entry throughout study duration . 9 . History allergy chlorhexidine , flurbiprofen nonsteroidal antiinflammatory drug ( NSAIDs ) . 10 . Subjects take Phenytoin , calcium channel blocker drug ( CCBs ) and/or cyclosporine , might influence pattern tissue response . 11 . Subjects treat nonsteroidal antiinflammatory drug ( NSAIDs ) within 14 day prior entry study throughout study duration . 12 . Presence follow condition : Type 1 diabetes , major recurrent aphtae , stomatitis , abscess related oral pathology . 13 . The presence medical psychiatric condition opinion investigator could affect successful participation subject study . 14 . Subject participate clinical study 30 day prior start study throughout study duration . 15 . Subject use chlorhexidine oral rinses/ mouthwash regular basis .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Subjects , age &gt; 21 , Chronic periodontal disease natural teeth characterize presence least 2 teeth periodontal</keyword>
	<keyword>pocket 5-9 mm depth demonstrate bleed probe without involve</keyword>
	<keyword>apex tooth confirm dental X-ray .</keyword>
</DOC>